The DOI matches its Crossref record; 70 of the 70 references it cites were found in a registry or an index.
Epidermal Growth Factor Receptor Biology in Head and Neck Cancer
Abstract
Epidermal growth factor receptor (EGFR) is overexpressed in several epithelial malignancies, including head and neck squamous cell carcinoma (HNSCC), which exhibits EGFR overexpression in up to 90% of tumors. EGFR ligands such as transforming growth factor alpha are also overexpressed in HNSCC. EGFR plays a critical role in HNSCC growth, invasion, metastasis and angiogenesis. However, EGFR inhibitors as monotherapy have yielded only modest clinical outcomes. Potential mechanisms for lack of response to EGFR inhibition in HNSCC include constitutive activation of signaling pathways independent of EGFR, as well as genetic aberrations causing dysregulation of the cell cycle. EGFR-directed therapy may be optimized by identifying and selecting those HNSCC patients most likely to benefit from EGFR inhibition. Resistance to EGFR inhibition may be circumvented by combination therapy employing EGFR inhibitors together with other treatment modalities.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
1 retracted
Pedrero, J. M. G., Carracedo, D. G., Pinto, C. M., Zapatero, A. H., Rodrigo, J. P., Nieto, C. S., & Gonzalez, M. V. (2005) · International Journal of Cancer · doi:10.1002/ijc.20711 · Cited by 235
RetractedLynch, T. J., Bell, D. W., Sordella, R., Gurubhagavatula, S., Okimoto, R. A., Brannigan, B. W., Harris, P. L., Haserlat, S. M., Supko, J. G., Haluska, F. G., et al. (2004) · New England Journal of Medicine · doi:10.1056/nejmoa040938 · Cited by 11,486
EGFR Mutations in Lung Cancer: Correlation with Clinical Response to Gefitinib Therapy
Paez, J. G., Jänne, P. A., Lee, J. C., Tracy, S., Greulich, H., Gabriel, S., Herman, P., Kaye, F. J., Lindeman, N., Boggon, T. J., et al. (2004) · Science · doi:10.1126/science.1099314 · Cited by 9,368
ERBB receptors and cancer: the complexity of targeted inhibitors
Hynes, N. E., & Lane, H. A. (2005) · Nature Reviews Cancer · doi:10.1038/nrc1609 · Cited by 3,313
Nuclear localization of EGF receptor and its potential new role as a transcription factor
Lin, S.-Y., Makino, K., Xia, W., Matin, A., Wen, Y., Kwong, K. Y., Bourguignon, L., & Hung, M.-C. (2001) · Nature Cell Biology · doi:10.1038/ncb0901-802 · Cited by 1,064
Irreversible inhibitors of the EGF receptor may circumvent acquired resistance to gefitinib
Kwak, E. L., Sordella, R., Bell, D. W., Godin-Heymann, N., Okimoto, R. A., Brannigan, B. W., Harris, P. L., Driscoll, D. R., Fidias, P., Lynch, T. J., et al. (2005) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0502860102 · Cited by 952
Grandis, J. R., & Tweardy, D. J. (1993) · PubMed · Cited by 851
Self-citationPai, R., Soreghan, B., Szabo, I. L., Pavelka, M., Baatar, D., & Tarnawski, A. S. (2002) · Nature Medicine · doi:10.1038/nm0302-289 · Cited by 836
Thomson, S., Buck, E., Petti, F., Griffin, G., Brown, E., Ramnarine, N., Iwata, K. K., Gibson, N., & Haley, J. D. (2005) · Cancer Research · doi:10.1158/0008-5472.can-05-1058 · Cited by 663
High frequency of p16 (CDKN2/MTS-1/INK4A) inactivation in head and neck squamous cell carcinoma.
Reed, A. L., Califano, J. A., Cairns, P., Westra, W. H., Jones, R. M., Koch, W. M., Ahrendt, S. A., Eby, Y. J., Sewell, D. A., Nawroz, H., et al. (1996) · PubMed · Cited by 662
The ErbB receptors and their role in cancer progression
Holbro, T. (2003) · Experimental Cell Research · doi:10.1016/s0014-4827(02)00099-x · Cited by 608
The incidence of p53 mutations increases with progression of head and neck cancer.
Boyle, J. O., Hakim, J., Koch, W. M., van der Riet, P., Hruban, R. H., Roa, R. A., Correo, R., Eby, Y. J., Ruppert, J. M., & Sidransky, D. (1993) · PubMed · Cited by 598
Grandis, J. R., Drenning, S. D., Zeng, Q., Watkins, S. C., Melhem, M. F., Endo, S., Johnson, D. E., Huang, L., He, Y., & Kim, J. D. (2000) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.97.8.4227 · Cited by 588
Self-citationMoasser, M. M., Basso, A., Averbuch, S. D., & Rosen, N. X. (2001) · PubMed · Cited by 555
Nuclear interaction of EGFR and STAT3 in the activation of the iNOS/NO pathway
Lo, H.-W., Hsu, S.-C., Ali-Seyed, M., Gunduz, M., Xia, W., Wei, Y., Bartholomeusz, G., Shih, J.-Y., & Hung, M.-C. (2005) · Cancer Cell · doi:10.1016/j.ccr.2005.05.007 · Cited by 544
Grandis, J. R., Drenning, S. D., Chakraborty, A., Zhou, M. Y., Zeng, Q., Pitt, A. S., & Tweardy, D. J. (1998) · Journal of Clinical Investigation · doi:10.1172/jci3785 · Cited by 507
Self-citationEngelman, J. A., Jänne, P. A., Mermel, C., Pearlberg, J., Mukohara, T., Fleet, C., Cichowski, K., Johnson, B. E., & Cantley, L. C. (2005) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0409773102 · Cited by 493
Buchanan, F. G., Wang, D., Bargiacchi, F., & DuBois, R. N. (2003) · Journal of Biological Chemistry · doi:10.1074/jbc.m302474200 · Cited by 463
Gschwind, A., Zwick, E., Prenzel, N., Leserer, M., & Ullrich, A. (2001) · Oncogene · doi:10.1038/sj.onc.1204192 · Cited by 462
Amann, J., Kalyankrishna, S., Massion, P. P., Ohm, J. E., Girard, L., Shigematsu, H., Peyton, M., Juroske, D., Huang, Y., Stuart Salmon, J., et al. (2005) · Cancer Research · doi:10.1158/0008-5472.226.65.1 · Cited by 436
Self-citationBurke, P., Schooler, K., & Wiley, H. S. (2001) · Molecular Biology of the Cell · doi:10.1091/mbc.12.6.1897 · Cited by 383
Akt Phosphorylation and Gefitinib Efficacy in Patients With Advanced Non-Small-Cell Lung Cancer
Cappuzzo, F., Magrini, E., Ceresoli, G. L., Bartolini, S., Rossi, E., Ludovini, V., Gregorc, V., Ligorio, C., Cancellieri, A., Damiani, S., et al. (2004) · JNCI Journal of the National Cancer Institute · doi:10.1093/jnci/djh217 · Cited by 362
Cross-talk between Epidermal Growth Factor Receptor and c-Met Signal Pathways in Transformed Cells*
Jo, M., Stolz, D. B., Esplen, J. E., Dorko, K., Michalopoulos, G. K., & Strom, S. C. (2000) · Journal of Biological Chemistry · doi:10.1074/jbc.275.12.8806 · Cited by 347
Pece, S., & Gutkind, J. S. (2000) · Journal of Biological Chemistry · doi:10.1074/jbc.m006578200 · Cited by 345
TACE cleavage of proamphiregulin regulates GPCR-induced proliferation and motility of cancer cells
Gschwind, A. (2003) · The EMBO Journal · doi:10.1093/emboj/cdg231 · Cited by 342
Worthylake, R., Opresko, L. K., & Wiley, H. S. (1999) · Journal of Biological Chemistry · doi:10.1074/jbc.274.13.8865 · Cited by 325
Signaling through the epidermal growth factor receptor during the development of malignancy
Grandis, J. R., & Sok, J. C. (2004) · Pharmacology & Therapeutics · doi:10.1016/j.pharmthera.2004.01.002 · Cited by 320
Self-citationCoffey, R. J., Hawkey, C. J., Damstrup, L., Graves-Deal, R., Daniel, V. C., Dempsey, P. J., Chinery, R., Kirkland, S. C., DuBois, R. N., Jetton, T. L., et al. (1997) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.94.2.657 · Cited by 316
Binding at and transactivation of the COX-2 promoter by nuclear tyrosine kinase receptor ErbB-2
Wang, S.-C., Lien, H.-C., Xia, W., Chen, I.-F., Lo, H.-W., Wang, Z., Ali-Seyed, M., Lee, D.-F., Bartholomeusz, G., Ou-Yang, F., et al. (2004) · Cancer Cell · doi:10.1016/j.ccr.2004.07.012 · Cited by 305
Ono, M., Hirata, A., Kometani, T., Miyagawa, M., Ueda, S.-I., Kinoshita, H., Fujii, T., & Kuwano, M. (2004) · Molecular Cancer Therapeutics · doi:10.1158/1535-7163.465.3.4 · Cited by 305
Motoyama, A. B., Hynes, N. E., & Lane, H. A. (2002) · PubMed · Cited by 286
Albanell, J., Codony‐Servat, J., Rojo, F., Campo, J. M. D., Sauleda, S., Anido, J., Raspall, G., Giralt, J., Roselló, J., Nicholson, R. I., et al. (2001) · PubMed · Cited by 273
Psyrri, A., Yu, Z., Weinberger, P. M., Sasaki, C., Haffty, B., Camp, R., Rimm, D., & Burtness, B. A. (2005) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-05-0420 · Cited by 269
Clayton, A. H. A., Walker, F., Orchard, S. G., Henderson, C., Fuchs, D., Rothacker, J., Nice, E. C., & Burgess, A. W. (2005) · Journal of Biological Chemistry · doi:10.1074/jbc.m504770200 · Cited by 256
Amador, M. L., Oppenheimer, D., Perea, S., Maitra, A., Cusati, G., Iacobuzio-Donahue, C., Baker, S. D., Ashfaq, R., Takimoto, C., Forastiere, A., et al. (2004) · Cancer Research · doi:10.1158/0008-5472.can-04-1036 · Cited by 241
Somatic Mutations of EGFR Gene in Squamous Cell Carcinoma of the Head and Neck
Lee, J. W., Soung, Y. H., Kim, S. Y., Nam, H. K., Park, W. S., Nam, S. W., Kim, M. S., Sun, D. I., Lee, Y. S., Jang, J. J., et al. (2005) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-04-2029 · Cited by 236
Krysan, K., Reckamp, K. L., Dalwadi, H., Sharma, S., Rozengurt, E., Dohadwala, M., & Dubinett, S. M. (2005) · Cancer Research · doi:10.1158/0008-5472.can-05-0216 · Cited by 234
Molina‐Vila, M. Á., Sáez, R., Ramsey, E. E., Garcia-Barchino, M. J., Rojo, F., Evans, A. J., Albanell, J., Keenan, E. J., Lluch, A. M., García-Conde, J., et al. (2002) · PubMed · Cited by 232
Ishikawa, N., Daigo, Y., Takano, A., Taniwaki, M., Kato, T., Hayama, S., Murakami, H., Takeshima, Y., Inai, K., Nishimura, H., et al. (2005) · Cancer Research · doi:10.1158/0008-5472.can-05-1556 · Cited by 194
Biological significance of c-erbB family oncogenes in head and neck cancer
Rogers, S. J., Harrington, K. J., Rhys-Evans, P., O-Charoenrat, P., & Eccles, S. A. (2005) · Cancer and Metastasis Reviews · doi:10.1007/s10555-005-5047-1 · Cited by 186
木島, 太., Niwa, H., Steinman, R. A., Drenning, S. D., Gooding, W. E., Wentzel, A. L., Xi, S., & Grandis, J. R. (2002) · PubMed · Cited by 177
Self-citationPrediction of sensitivity of advanced non-small cell lung cancers to gefitinib (Iressa, ZD1839)
Kakiuchi, S., Daigo, Y., Ishikawa, N., Furukawa, C., Tsunoda, T., Yano, S., Nakagawa, K., Tsuruo, T., Kohno, N., Fukuoka, M., et al. (2004) · Human Molecular Genetics · doi:10.1093/hmg/ddh331 · Cited by 173
Nuclear localization and possible functions of receptor tyrosine kinases
Carpenter, G. (2003) · Current Opinion in Cell Biology · doi:10.1016/s0955-0674(03)00015-2 · Cited by 169
Zhang, Q., Thomas, S. M., Xi, S., Smithgall, T. E., Siegfried, J. M., Kamens, J., Gooding, W. E., & Grandis, J. R. (2004) · Cancer Research · doi:10.1158/0008-5472.can-04-0504 · Cited by 167
Self-citationSTAT5b, a Mediator of Synergism between c-Src and the Epidermal Growth Factor Receptor
Kloth, M. T., Laughlin, K. K., Biscardi, J. S., Boerner, J. L., Parsons, S. J., & Silva, C. M. (2003) · Journal of Biological Chemistry · doi:10.1074/jbc.m207289200 · Cited by 166
Analysis of PTEN/MMAC1 alterations in aerodigestive tract tumors.
Okami, K., Wu, L. J., Riggins, G. J., Cairns, P., Goggins, M., Evron, E., Halachmi, N., Ahrendt, S. A., Reed, A. L., Hilgers, W., et al. (1998) · PubMed · Cited by 163
Ogino, S., Meyerhardt, J. A., Cantor, M., Brahmandam, M., Clark, J. W., Namgyal, C., Kawasaki, T., Kinsella, K., Michelini, A. L., Enzinger, P. C., et al. (2005) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-05-0738 · Cited by 162
Moraitis, D., Du, B., Lorenzo, M. S. D., Boyle, J. O., Weksler, B. B., Cohen, E. G., Carew, J. F., Altorki, N. K., Kopelovich, L., Subbaramaiah, K., et al. (2005) · Cancer Research · doi:10.1158/0008-5472.664.65.2 · Cited by 141
Shen, X., & Kramer, R. H. (2004) · American Journal Of Pathology · doi:10.1016/s0002-9440(10)63390-1 · Cited by 124
Expression of Protein Tyrosine Kinases in Head and Neck Squamous Cell Carcinomas
Ongkeko, W. M., Altuna, X., Weisman, R. A., & Wang‐Rodriguez, J. (2005) · American Journal of Clinical Pathology · doi:10.1309/btln-5wtm-j3pc-nrrc · Cited by 117
EGF/ErbB Receptor Family in Ovarian Cancer
Maihle, N. J., Baron, A. T., Barrette, B. A., Boardman, C. H., Christensen, T. A., Cora, E. M., Faupel‐Badger, J. M., Greenwood, T. M., Juneja, S. C., Lafky, J. M., et al. (2002) · Springer eBooks · doi:10.1007/978-1-4757-3587-1_11 · Cited by 116
Constitutive activation of Stat5b contributes to carcinogenesis in vivo.
Xi, S., Zhang, Q. H., Gooding, W. E., Smithgall, T. E., & Grandis, J. R. (2003) · PubMed · Cited by 114
Self-citationVascular endothelial growth factor expression in head and neck squamous cell carcinoma
Eisma, R. J., Spiro, J. D., & Kreutzer, D. L. (1997) · The American Journal of Surgery · doi:10.1016/s0002-9610(97)00166-9 · Cited by 111
Thomas, S. M., Coppelli, F. M., Wells, A. H., Gooding, W. E., Song, J. I., Kassis, J. N., Drenning, S. D., & Grandis, J. R. (2003) · PubMed · Cited by 110
Self-citationHirata, A., Hosoi, F., Miyagawa, M., Ueda, S.-I., Naito, S., Fujii, T., Kuwano, M., & Ono, M. (2005) · Cancer Research · doi:10.1158/0008-5472.can-04-2748 · Cited by 109
Hart, S., Fischer, O. M., Prenzel, N., Zwick-Wallasch, E., Schneider, M., Hennighausen, L. G., & Ullrich, A. (2005) · Biological Chemistry · doi:10.1515/bc.2005.099 · Cited by 105
Hurbin, A., Dubrez, L., Coll, J., & Favrot, M. (2002) · Journal of Biological Chemistry · doi:10.1074/jbc.m207584200 · Cited by 102
Wang, J., Zhang, X., Thomas, S. M., Grandis, J. R., Wells, A. H., Chen, Z., & Ferris, R. L. (2005) · Oncogene · doi:10.1038/sj.onc.1208740 · Cited by 100
Self-citationO‐charoenrat, P., Rhys‐Evans, P. H., Modjtahedi, H., & Eccles, S. A. (2000) · Clinical & Experimental Metastasis · doi:10.1023/a:1006764100867 · Cited by 99
Adams, T. E., McKern, N. M., & Ward, C. W. (2004) · Growth Factors · doi:10.1080/08977190410001700998 · Cited by 97
Bei, R., Budillon, A., Masuelli, L., Cereda, V., Vitolo, D., Gennaro, E. D., Ripavecchia, V., Palumbo, C., Ionna, F., Losito, S., et al. (2004) · The Journal of Pathology · doi:10.1002/path.1642 · Cited by 95
Sini, P., Wyder, L., Schnell, C., O’Reilly, T., Littlewood, A., Brandt, R., Hynes, N. E., & Wood, J. M. (2005) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-04-1954 · Cited by 87
Timpson, P., Lynch, D. K., Schramek, D., Walker, F., & Daly, R. J. (2005) · Cancer Research · doi:10.1158/0008-5472.can-04-2118 · Cited by 78
Weber, F., Fukino, K., Sawada, T., Williams, N., Sweet, K. M., Brena, R. M., Plass, C., Caldés, T., Mutter, G. L., Villalona-Calero, M. A., et al. (2005) · British Journal of Cancer · doi:10.1038/sj.bjc.6602557 · Cited by 75
Mutant Epidermal Growth Factor Receptors as Targets for Cancer Therapy
Lorimer, I. A. J. (2002) · Current Cancer Drug Targets · doi:10.2174/1568009023333926 · Cited by 68
Du, B., Altorki, N. K., Kopelovich, L., Subbaramaiah, K., & Dannenberg, A. J. (2005) · Cancer Research · doi:10.1158/0008-5472.can-05-0628 · Cited by 62
Riedel, F., Götte, K., Li, M., Hörmann, K., & Grandis, J. R. (2002) · International Journal of Oncology · doi:10.3892/ijo.21.1.11 · Cited by 58
Self-citationMYC Amplification in Squamous Cell Carcinomas of the Head and Neck
Rodrigo, J. P., Lazo, P. S., Ramos, S., Álvarez, I. Á., & Suarez, C. M. (1996) · Archives of Otolaryngology - Head and Neck Surgery · doi:10.1001/archotol.1996.01890170038008 · Cited by 55
Expression and regulation of c-erbB ligands in human head and neck squamous carcinoma cells
O‐charoenrat, P., Rhys‐Evans, P. H., & Eccles, S. A. (2000) · International Journal of Cancer · doi:10.1002/1097-0215(20001201)88:5<759::aid-ijc12>3.0.co;2-0 · Cited by 53
Sithanandam, G., Smith, G. T., Fields, J. R., Fornwald, L. W., & Anderson, L. M. (2005) · American Journal of Respiratory Cell and Molecular Biology · doi:10.1165/rcmb.2005-0049oc · Cited by 33
Cited by
Bhirde, A. A., Patel, V., Gavard, J., Zhang, G., Sousa, A. A., Masedunskas, A., Leapman, R. D., Weigert, R., Gutkind, J. S., & Rusling, J. F. (2009) · ACS Nano · doi:10.1021/nn800551s · Cited by 853
The changing therapeutic landscape of head and neck cancer
Cramer, J. D., Burtness, B., Le, Q. T., & Ferris, R. L. (2019) · Nature Reviews Clinical Oncology · doi:10.1038/s41571-019-0227-z · Cited by 783
Head and Neck Cancer: Changing Epidemiology, Diagnosis, and Treatment
Marur, S., & Forastiere, A. A. (2008) · Mayo Clinic Proceedings · doi:10.4065/83.4.489 · Cited by 739
Kumar, B., Cordell, K. G., Lee, J. S., Worden, F. P., Prince, M. E., Tran, H. H., Wolf, G. T., Urba, S. G., Chepeha, D. B., Teknos, T. N., et al. (2008) · Journal of Clinical Oncology · doi:10.1200/jco.2007.12.7662 · Cited by 612
Molecular Pathogenesis of Oral Squamous Cell Carcinoma: Implications for Therapy
Choi, S., & Myers, J. N. (2008) · Journal of Dental Research · doi:10.1177/154405910808700104 · Cited by 516
Metadata
- Authors
- Kalyankrishna, S., & Grandis, J. R.
- Venue
- Journal of Clinical Oncology
- Published
- 2006-06-10
- Volume
- 24
- Issue
- 17
- Pages
- 2666-2672
- ISSN
- 0732-183X (ISSN-L)
- 1527-7755
- OpenAlex
- W2089663915
- Cited by
- 747
- References
- 70
- FWCI
- 17.21
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.